Jeremy’s work at ZS is focused on various facets of marketing strategy, including opportunity assessment, positioning, segmentation and forecasting. He has spent his career on marketing and sales issues in the pharmaceutical and biotech industries.
Jeremy has special expertise in new product development as well as business development and licensing. In these roles, he has gained experience in supporting a range of strategic marketing initiatives through qualitative and quantitative market research, secondary data analysis including patient longitudinal data, and forecasting. He has helped clients make hundreds of “go/no go” clinical development decisions across dozens of therapy areas.
Before joining ZS in 2009, Jeremy worked with Johnson & Johnson and Neurocrine Biosciences, and as a consultant with Trinity Partners.
Jeremy holds an MBA from the Fuqua School of Business at Duke University, with a concentration in health sector management, and an A.B. from Harvard University.